📰 Nasdaq Rules News
Page 9 - Nasdaq Rules News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Rules. Real-time updates on events, politics, business and more.
February 3, 2022
/PRNewswire/ -- Ucommune International Ltd. (NASDAQ: UK) ("Ucommune" or the "Company"), a leading agile office space manager and provider in China, today...
December 16, 2021
- The NYSE first amended its shareholder approval rules largely to make permanent The temporary accommodations that were put into effect at the onset…
December 7, 2021
/PRNewswire/ -- VectoIQ Acquisition Corp. II (Nasdaq: VTIQU, VTIQ, VTIQW) (the "Company") today announced that on December 1, 2021 it received a deficiency...
December 7, 2021
/PRNewswire/ -- VectoIQ Acquisition Corp. II (Nasdaq: VTIQU, VTIQ, VTIQW) (the "Company") today announced that on December 1, 2021 it received a deficiency...
December 3, 2021
The Securities and Exchange Commission approved, effective immediately, the New York Stock Exchange’s NYSE proposed amendment to Rule 312.07, which governs the treatment of shareholder votes and abstentions.
November 4, 2021
A broker-dealer settled Nasdaq Stock Market LLC charges that its "market access" controls were deficient.
November 3, 2021
/PRNewswire/ -- Oramed Pharmaceuticals Inc. ("Oramed" or the "Company") (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company...
November 3, 2021
/PRNewswire/ -- Oramed Pharmaceuticals Inc. ("Oramed" or the "Company") (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company...
September 11, 2021
/PRNewswire/ -- ReTo Eco-Solutions, Inc. (NASDAQ: RETO) ("ReTo" or the "Company"), a provider of technology solutions for the improvement of ecological...
June 1, 2021
Share this article Share this article NEW YORK, June 1, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Wunong Net Technology Company Limited ("Wunong" or the "Company") (NASDAQ: WNW). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Wunong and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. O...